Gsk
- All
- News
- Videos
-
Pharma Giant GSK Fires Employee After Video Of His Abusive Meltdown On Flight Goes Viral
A man in the United States was fired from his job after being caught on video yelling homophobic, racist slurs during a flight.
-
World's 1st Malaria Shot Won't Reach Millions Of Children. Here's Why
After decades of work, the World Health Organization endorsed the first-ever malaria vaccine last year - a historic milestone that promised to drive back a disease that kills a child every minute.
-
Eye On Investment, Telangana Minister KTR Meets UK Healthcare Giant
Telangana Minister KT Rama Rao on Thursday held a meeting with Global R&D Head GSK Consumer Health, Franck Riot and discussed the expansion plans of GlaxoSmithKline, a healthcare company, for the state.
-
CCI Okays Acquisition Of 100% Shares In GlaxoSmithKline Asia By Parent Group Entities
CCI has okayed the acquisition of GlaxoSmithKline Asia Private Limited shareholding by parent group companies
-
Unilever Shows Interest In GSK's Consumer Health Business
Dove soap maker Unilever signalled on Monday it would pursue a deal for GlaxoSmithKline's consumer health business
-
GlaxoSmithKline, SK Bioscience Start Final Trial Of COVID-19 Jab
British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a Covid-19 jab after positive early results, they announced Tuesday.
-
Sanofi And GSK Launch Final Testing Phase Of New Covid Vaccine
French pharmaceutical giant Sanofi and Britain's GSK announced Thursday the start of final tests of their belated Covid vaccine as they race to add their jab to the world's arsenal against the pandemic.
-
GSK Pharma Net Profit Falls 90% To Rs 14 Crore In March Quarter
GSK Pharma Q4 Results: GlaxoSmithKline (GSK) Pharmaceuticals reported a net profit of Rs 14.33 crore in the January-March quarter for the financial year 2020-21
-
Sanofi, GSK Say Covid Vaccine Shows Positive Result
French pharmaceuticals giant Sanofi and Britain's GSK reported Monday positive results in clinical trials of their Covid-19 jab following an earlier setback, raising hope it could be added to the world's vaccine arsenal.
-
UK Drugmaker GSK Transfers Malaria Vaccine Production To Bharat Biotech
Britain's GSK will shift production of the world's first effective malaria vaccine to Indian COVID-19 vaccine developer Bharat Biotech, as part of global efforts to battle the deadly fever, the drugmakers said on Wednesday.
-
Sanofi, GSK Covid Vaccine To Be Ready Only At The End Of 2021
France's Sanofi and Britain's GSK said Friday their Covid-19 vaccines will not be ready until the end of 2021, after interim results showed a low immune response in older adults.
-
Sanofi And GSK Launch Trial For COVID-19 Protein-Based Vaccine
French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments against the coronavirus pandemic.
-
Britain Nears 500 Million Pound Deal For Sanofi, GSK COVID-19 Vaccine: Report
Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of their potential COVID-19 vaccine, the Sunday Times reported.
-
Government Plans To Pull In 324 Companies Including Tesla, Glaxo: Report
Under the plan, the government will create a land bank for ready-to-move-in industrial clusters, offer investment and location-based incentives and rationalize anti-dumping duties.
-
GlaxoSmithKline To Split After Joint Venture Deal With Pfizer
GSK and Pfizer would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds ($12.7 billion), 68 per cent-owned by the British company, in an all-equity transaction.
-
Pharma Giant GSK Fires Employee After Video Of His Abusive Meltdown On Flight Goes Viral
A man in the United States was fired from his job after being caught on video yelling homophobic, racist slurs during a flight.
-
World's 1st Malaria Shot Won't Reach Millions Of Children. Here's Why
After decades of work, the World Health Organization endorsed the first-ever malaria vaccine last year - a historic milestone that promised to drive back a disease that kills a child every minute.
-
Eye On Investment, Telangana Minister KTR Meets UK Healthcare Giant
Telangana Minister KT Rama Rao on Thursday held a meeting with Global R&D Head GSK Consumer Health, Franck Riot and discussed the expansion plans of GlaxoSmithKline, a healthcare company, for the state.
-
CCI Okays Acquisition Of 100% Shares In GlaxoSmithKline Asia By Parent Group Entities
CCI has okayed the acquisition of GlaxoSmithKline Asia Private Limited shareholding by parent group companies
-
Unilever Shows Interest In GSK's Consumer Health Business
Dove soap maker Unilever signalled on Monday it would pursue a deal for GlaxoSmithKline's consumer health business
-
GlaxoSmithKline, SK Bioscience Start Final Trial Of COVID-19 Jab
British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a Covid-19 jab after positive early results, they announced Tuesday.
-
Sanofi And GSK Launch Final Testing Phase Of New Covid Vaccine
French pharmaceutical giant Sanofi and Britain's GSK announced Thursday the start of final tests of their belated Covid vaccine as they race to add their jab to the world's arsenal against the pandemic.
-
GSK Pharma Net Profit Falls 90% To Rs 14 Crore In March Quarter
GSK Pharma Q4 Results: GlaxoSmithKline (GSK) Pharmaceuticals reported a net profit of Rs 14.33 crore in the January-March quarter for the financial year 2020-21
-
Sanofi, GSK Say Covid Vaccine Shows Positive Result
French pharmaceuticals giant Sanofi and Britain's GSK reported Monday positive results in clinical trials of their Covid-19 jab following an earlier setback, raising hope it could be added to the world's vaccine arsenal.
-
UK Drugmaker GSK Transfers Malaria Vaccine Production To Bharat Biotech
Britain's GSK will shift production of the world's first effective malaria vaccine to Indian COVID-19 vaccine developer Bharat Biotech, as part of global efforts to battle the deadly fever, the drugmakers said on Wednesday.
-
Sanofi, GSK Covid Vaccine To Be Ready Only At The End Of 2021
France's Sanofi and Britain's GSK said Friday their Covid-19 vaccines will not be ready until the end of 2021, after interim results showed a low immune response in older adults.
-
Sanofi And GSK Launch Trial For COVID-19 Protein-Based Vaccine
French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments against the coronavirus pandemic.
-
Britain Nears 500 Million Pound Deal For Sanofi, GSK COVID-19 Vaccine: Report
Britain is close to agreeing a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of their potential COVID-19 vaccine, the Sunday Times reported.
-
Government Plans To Pull In 324 Companies Including Tesla, Glaxo: Report
Under the plan, the government will create a land bank for ready-to-move-in industrial clusters, offer investment and location-based incentives and rationalize anti-dumping duties.
-
GlaxoSmithKline To Split After Joint Venture Deal With Pfizer
GSK and Pfizer would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds ($12.7 billion), 68 per cent-owned by the British company, in an all-equity transaction.
